Literature DB >> 9085356

Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension.

A Holécyová1, J Török, I Bernátová, O Pechánová.   

Abstract

The responsiveness of isolated high-pressure (aorta, renal artery) and low-pressure vessels (pulmonary artery) was compared during systemic hypertension induced by chronic inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME) in rats. L-NAME (40 mg/kg/day) was given to animals in their drinking water. After 4 weeks of L-NAME treatment, systolic blood pressure increased by 37% as compared with that in the control group. Chronic L-NAME treatment resulted in significant reduction of endothelium-dependent relaxation to acetylcholine (10(-8) to 3 x 10(-6) mol/l) in both types of vessels. The reduced relaxation was not influenced by acute pretreatment with indomethacin (10(-5) mol/l), however, it was further reduced by acute pretreatment with additional L-NAME (10(-4) mol/l). L-arginine (10(-4) mol/l) improved the reduced relaxation. Endothelium-independent relaxation to sodium nitroprusside (10(-9) to 10(-6) mol/l) was unaffected by L-NAME treatment. beta-adrenoceptor-mediated relaxation to isoprenaline (10(-8) to 3 x 10(-6) mol/l) was also not influenced by chronic L-NAME treatment. Similar alterations in the responsiveness of high- and low-pressure vessels indicate rather the decisive role of nitric oxide restriction than that of elevated blood pressure in their development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9085356

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  9 in total

1.  Changes of sodium and ATP affinities of the cardiac (Na,K)-ATPase during and after nitric oxide deficient hypertension.

Authors:  N Vrbjar; I Bernátová; O Pechánová
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Pentaerythrityl tetranitrate attenuates structural changes in conduit arteries evoked by long-term NO-synthase inhibition.

Authors:  F Kristek
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Functional and morphological pattern of vascular responses in two models of experimental hypertension.

Authors:  J Török; F Kristek
Journal:  Exp Clin Cardiol       Date:  2001

4.  Effects of one resistance exercise session on vascular smooth muscle of hypertensive rats.

Authors:  Tharciano Luiz Teixeira Braga da Silva; Marcelo Mendonça Mota; Milene Tavares Fontes; João Eliakim Dos Santos Araújo; Vitor Oliveira Carvalho; Leonardo Rigoldi Bonjardim; Márcio Roberto Viana Santos
Journal:  Arq Bras Cardiol       Date:  2015-06-23       Impact factor: 2.000

5.  Ethyl Rosmarinate Prevents the Impairment of Vascular Function and Morphological Changes in L-NAME-Induced Hypertensive Rats.

Authors:  Rungusa Pantan; Jiraporn Tocharus; Archawin Nakaew; Apichart Suksamrarn; Chainarong Tocharus
Journal:  Medicina (Kaunas)       Date:  2019-12-07       Impact factor: 2.430

6.  Chronic L-Name-Treatment Produces Hypertension by Different Mechanisms in Peripheral Tissues and Brain: Role of Central eNOS.

Authors:  Olga Pechanova; Stanislava Vrankova; Martina Cebova
Journal:  Pathophysiology       Date:  2020-12-15

Review 7.  Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?

Authors:  Iveta Bernatova
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

8.  Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.

Authors:  Mahesh Kumar Seth; M Ejaz Hussain; Santosh Pasha; Mohammad Fahim
Journal:  Drug Des Devel Ther       Date:  2016-04-20       Impact factor: 4.162

9.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.